|
Dr. Scott Klarenbach is an Associate Professor in the Department of Medicine, Division of Nephrology at the University of Alberta in Edmonton; a Fellow at the Institute of Health Economics, and the Medical Director of Home Hemodialysis, Northern Alberta Renal Program. Dr. Klarenbach is a nephrologist and has an MSc in Health Economics from the University of York, in the United Kingdom. He has performed several economic evaluations, has been involved in several randomized trials, and collaborated on several systematic reviews. Dr. Klarenbach was involved in two full health technology assessments for CADTH, including the supervision of the economic evaluation, comparing continuous renal replacement therapy and intermittent hemodialysis as treatments for patients with acute renal failure in the ICU. Dr. Klarenbach was also undertaken pharmacoeconomic reviews for CADTH’s Common Drug Review.
|